Dataset Information

The heterogeneity of public ex situ collections of microorganisms: Empirical evidence about conservation practices, industry spillovers and public goods.

ABSTRACT: Public service (ex situ) micro-organism collections serve to secure genetic resources for unforeseen future needs, and importantly, to provide authenticated biomaterials for contemporaneous use in private and public entities and as upstream research materials. Hence, it is important to understand the functioning and strategic decisions of these providers of public good resources. The existing literature tends to use case studies of individual collections. This paper uses a unique worldwide survey of microbial collections to analyse the heterogeneity among culture collections, and to empirically assess the economic and institutional conditions that contribute to this heterogeneity with respect to conservation choice and associated industry spillovers. Results suggest that in the short run public-private partnerships may indeed support knowledge accumulation with particularly strong public good properties. It is important to be aware of this strong tie, in order to steer also the long term conservation patrimony into one that offers not only short term usability but also resilience to future unforeseen needs e.g. of emerging crop plagues.

SUBMITTER: Stromberg PM

PROVIDER: S-EPMC7106414 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

The heterogeneity of public ex situ collections of microorganisms: Empirical evidence about conservation practices, industry spillovers and public goods.

Stromberg Per M PM Dedeurwaerdere Tom T Pascual Unai U

Environmental science & policy 20130607

Public service (ex situ) micro-organism collections serve to secure genetic resources for unforeseen future needs, and importantly, to provide authenticated biomaterials for contemporaneous use in private and public entities and as upstream research materials. Hence, it is important to understand the functioning and strategic decisions of these providers of public good resources. The existing literature tends to use case studies of individual collections. This paper uses a unique worldwide surve ...[more]

PMID: 32288638

Similar Datasets

Project description:Although corporate social responsibility (CSR) activities are common in the pharmaceutical industry, there is little empirical evidence on consumer responses to CSR practices. We investigated public awareness, preferences, and expectations regarding social contribution of the pharmaceutical industry's CSR activities, and identified the factors associated with such activities. We conducted an online survey with 1,298 respondents comprising two groups: healthy individuals (546) and patients (752). Most respondents (78%) expressed interest in CSR activities undertaken by pharmaceutical companies. However, they reported a lack of awareness and experience thereof; only 26.9% were aware of and 7.9% had experience with such activities. Among our six CSR activity categories, both survey groups showed the highest preference for the "promoting public health" (healthy group: 6.34/10; patient group: 6.37/10) and "emergency disaster relief support" (6.31 and 6.35) categories. Among sub-categories, activities related to "development of innovative drugs in untreated areas" (6.63 and 6.82) and "support for research on new drug development" (6.59 and 6.84) received the highest scores. The mean expectation score of social contribution of all CSR activities was slightly higher than the mean preference score (6.37 and 6.06, respectively). The patient group exhibited a larger difference between the highest and lowest expectation scores than the healthy group (1.11 and 0.64, respectively). The results of the regression analysis revealed that being a patient, being male, and having positive attitudes toward CSR and its expected effects significantly and positively affected public preferences regarding CSR activities. We can conclude that CSR activities with high public preference might be an effective strategy to improve public awareness of the pharmaceutical industry's CSR activities. Furthermore, the highest preference for CSR activities relates to new drug development, indicating that our society believes the pharmaceutical industry's key CSR activity should be to pursue its intrinsic mission: to fulfill unmet medical needs by developing new drugs.

Dataset Information

The heterogeneity of public ex situ collections of microorganisms: Empirical evidence about conservation practices, industry spillovers and public goods.

Publications

The heterogeneity of public ex situ collections of microorganisms: Empirical evidence about conservation practices, industry spillovers and public goods.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets